28005811000001106: Sastravi 175mg/43.75mg/200mg tablets (Actavis UK Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Sastravi 175mg/43.75mg/200mg tablets (Actavis UK Ltd)
\UK product\Virtual medicinal product\Generic Stalevo 175mg/43.75mg/200mg tablets\Sastravi 175mg/43.75mg/200mg tablets (Actavis UK Ltd)
\UK product\Virtual therapeutic moiety\Levodopa + Carbidopa + Entacapone\Generic Stalevo 175mg/43.75mg/200mg tablets\Sastravi 175mg/43.75mg/200mg tablets (Actavis UK Ltd)
\UK product\Trade family\Sastravi\Sastravi 175mg/43.75mg/200mg tablets (Actavis UK Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing dihydroxyphenylalanine decarboxylase inhibitor\Product containing carbidopa\Product containing carbidopa and levodopa\Product containing carbidopa and entacapone and levodopa\Levodopa + Carbidopa + Entacapone\Generic Stalevo 175mg/43.75mg/200mg tablets\Sastravi 175mg/43.75mg/200mg tablets (Actavis UK Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing methyltransferase inhibitor\Product containing catechol-O-methyltransferase inhibitor\Product containing entacapone\Product containing carbidopa and entacapone and levodopa\Levodopa + Carbidopa + Entacapone\Generic Stalevo 175mg/43.75mg/200mg tablets\Sastravi 175mg/43.75mg/200mg tablets (Actavis UK Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing dopamine receptor agonist\Product containing carbidopa\Product containing carbidopa and levodopa\Product containing carbidopa and entacapone and levodopa\Levodopa + Carbidopa + Entacapone\Generic Stalevo 175mg/43.75mg/200mg tablets\Sastravi 175mg/43.75mg/200mg tablets (Actavis UK Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing dopamine receptor agonist\Product containing levodopa\Product containing carbidopa and levodopa\Product containing carbidopa and entacapone and levodopa\Levodopa + Carbidopa + Entacapone\Generic Stalevo 175mg/43.75mg/200mg tablets\Sastravi 175mg/43.75mg/200mg tablets (Actavis UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing catecholamine\Product containing carbidopa\Product containing carbidopa and levodopa\Product containing carbidopa and entacapone and levodopa\Levodopa + Carbidopa + Entacapone\Generic Stalevo 175mg/43.75mg/200mg tablets\Sastravi 175mg/43.75mg/200mg tablets (Actavis UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing catecholamine\Product containing levodopa\Product containing carbidopa and levodopa\Product containing carbidopa and entacapone and levodopa\Levodopa + Carbidopa + Entacapone\Generic Stalevo 175mg/43.75mg/200mg tablets\Sastravi 175mg/43.75mg/200mg tablets (Actavis UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing entacapone\Product containing carbidopa and entacapone and levodopa\Levodopa + Carbidopa + Entacapone\Generic Stalevo 175mg/43.75mg/200mg tablets\Sastravi 175mg/43.75mg/200mg tablets (Actavis UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing phenol structure (product)\Product containing entacapone\Product containing carbidopa and entacapone and levodopa\Levodopa + Carbidopa + Entacapone\Generic Stalevo 175mg/43.75mg/200mg tablets\Sastravi 175mg/43.75mg/200mg tablets (Actavis UK Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing carbidopa\Product containing carbidopa and levodopa\Product containing carbidopa and entacapone and levodopa\Levodopa + Carbidopa + Entacapone\Generic Stalevo 175mg/43.75mg/200mg tablets\Sastravi 175mg/43.75mg/200mg tablets (Actavis UK Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing entacapone\Product containing carbidopa and entacapone and levodopa\Levodopa + Carbidopa + Entacapone\Generic Stalevo 175mg/43.75mg/200mg tablets\Sastravi 175mg/43.75mg/200mg tablets (Actavis UK Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing levodopa\Product containing carbidopa and levodopa\Product containing carbidopa and entacapone and levodopa\Levodopa + Carbidopa + Entacapone\Generic Stalevo 175mg/43.75mg/200mg tablets\Sastravi 175mg/43.75mg/200mg tablets (Actavis UK Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 10-Dec 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

88046101000001114 Sastravi 175mg/43.75mg/200mg tablets (Actavis UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

88046201000001119 Sastravi 175mg/43.75mg/200mg tablets (Actavis UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Sastravi 175mg/43.75mg/200mg tablets (Actavis UK Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Sastravi 175mg/43.75mg/200mg tablets (Actavis UK Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Sastravi 175mg/43.75mg/200mg tablets (Actavis UK Ltd)	Is a	Generic Stalevo 175mg/43.75mg/200mg tablets	true	Inferred relationship	Existential restriction modifier
Sastravi 175mg/43.75mg/200mg tablets (Actavis UK Ltd)	Has active ingredient	Carbidopa	true	Inferred relationship	Existential restriction modifier
Sastravi 175mg/43.75mg/200mg tablets (Actavis UK Ltd)	Has active ingredient	Entacapone	true	Inferred relationship	Existential restriction modifier
Sastravi 175mg/43.75mg/200mg tablets (Actavis UK Ltd)	Has active ingredient	Levodopa	true	Inferred relationship	Existential restriction modifier
Sastravi 175mg/43.75mg/200mg tablets (Actavis UK Ltd)	VMP prescribing status (attribute)	Never valid to prescribe as a VMP	false	Inferred relationship	Existential restriction modifier
Sastravi 175mg/43.75mg/200mg tablets (Actavis UK Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Sastravi 175mg/43.75mg/200mg tablets (Actavis UK Ltd)	Has specific active ingredient	Carbidopa	true	Inferred relationship	Existential restriction modifier
Sastravi 175mg/43.75mg/200mg tablets (Actavis UK Ltd)	Has specific active ingredient	Levodopa	true	Inferred relationship	Existential restriction modifier
Sastravi 175mg/43.75mg/200mg tablets (Actavis UK Ltd)	Has specific active ingredient	Entacapone	true	Inferred relationship	Existential restriction modifier
Sastravi 175mg/43.75mg/200mg tablets (Actavis UK Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Sastravi 175mg/43.75mg/200mg tablets (Actavis UK Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Sastravi 175mg/43.75mg/200mg tablets (Actavis UK Ltd)	Is a	Sastravi	true	Inferred relationship	Existential restriction modifier
Sastravi 175mg/43.75mg/200mg tablets (Actavis UK Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Sastravi 175mg/43.75mg/200mg tablets (Actavis UK Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Sastravi 175mg/43.75mg/200mg tablets (Actavis UK Ltd)	Has manufactured dose form	Tablet	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Sastravi 175mg/43.75mg/200mg tablets (Actavis UK Ltd) 30 tablet	Has AMP	True	Sastravi 175mg/43.75mg/200mg tablets (Actavis UK Ltd)	Inferred relationship	Existential restriction modifier
Sastravi 175mg/43.75mg/200mg tablets (Actavis UK Ltd) 100 tablet	Has AMP	True	Sastravi 175mg/43.75mg/200mg tablets (Actavis UK Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
88046101000001114	Sastravi 175mg/43.75mg/200mg tablets (Actavis UK Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
88046201000001119	Sastravi 175mg/43.75mg/200mg tablets (Actavis UK Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module